In the field of human health and social work activities in Italy, business enterprise R&D expenditure is forecasted to grow significantly from 2024 to 2028. Starting at $465.29 million PPP in 2024, it is expected to reach $556.01 million PPP by 2028. This represents a year-on-year increase of around 4.91% and a compound annual growth rate (CAGR) of approximately 4.60% from 2024. As of 2023, the R&D expenditure registered at $442.55 million PPP.
Future trends to watch for:
- Increased integration of digital technologies and Artificial Intelligence in healthcare R&D.
- Rising focus on biotechnology and pharmaceutical developments driven by global health challenges.
- Potential policy incentives and funding from both Italian government and European Union to boost R&D investments.
- Shifts in global economic conditions impacting the funding and strategic focus areas of enterprises.
